Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Streptococcus dentisani CECT 7746 in Caries Risk Reduction
NCT03468842Phase 1Completed
- Sponsor
- AB-BIOTICS
- Start
- May 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of streptococcus dentisani CECT 7746 in dental caries (2 arms), sponsored by AB-BIOTICS. Primary endpoints: Change from baseline Salivary pH before and after brushing with water at 45 days and Adverse effects. Started May 2016; status: completed.
02
Drugs
streptococcus dentisani CECT 7746
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03468842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468842.